The weekly litigation news digest is live. Subscribe now

IP Verse

Cd19 Specific Chimeric Antigen Receptor And Uses Thereof - EP2997141

The patent EP2997141 was granted to Cellectis on Oct 12, 2022. The application was originally filed on May 12, 2014 under application number EP14723436A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2997141

CELLECTIS
Application Number
EP14723436A
Filing Date
May 12, 2014
Status
Granted And Under Opposition
Sep 9, 2022
Publication Date
Oct 12, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ACOPATJul 12, 2023IZQUIERDO BLANCOADMISSIBLE

Patent Citations (4) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONUS2008131415
INTERNATIONAL-SEARCH-REPORTWO2012129514
OPPOSITIONWO2012099973
OPPOSITIONWO2012129414

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents